SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-100452
Filing Date
2020-04-07
Accepted
2020-04-07 16:03:56
Documents
6
Effectiveness Date
2020-04-07

Document Format Files

Seq Description Document Type Size
1 DEFA14A d907305ddefa14a.htm DEFA14A 77577
2 GRAPHIC g907305img001_v1.jpg GRAPHIC 2387
3 GRAPHIC g907305img002_v1.jpg GRAPHIC 2243
4 GRAPHIC g907305img003_v1.jpg GRAPHIC 2253
5 GRAPHIC g907305img004_v1.jpg GRAPHIC 2254
6 GRAPHIC g907305img005_v1.jpg GRAPHIC 2239
  Complete submission text file 0001193125-20-100452.txt   95057
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 20779742
SIC: 2836 Biological Products, (No Diagnostic Substances)